Anest. intenziv. Med. 2013;24(6):396-402
Post-transplant right ventricular failure managementIntesive Care Medicine - Review Article
- 1 Klinika anesteziologie a resuscitace, IKEM, Praha
- 2 Klinika kardiologie, IKEM, Praha
- 3 Klinika kardiovaskulární chirurgie, IKEM, Praha
The presence of increased pulmonary artery pressure represents a major risk factor for post-transplant right ventricular failure. In principle the donor heart, which is not adapted to elevated pulmonary vascular resistance, is exposed to pulmonary hypertension in the recipient. Postoperative right ventricular dysfunction is a major cause of morbidity and mortality and despite advances in the peri-operative management, right ventricular dysfunction accounts for 20 % postoperative complications and early deaths in patients after heart transplantation. The presence, grade and reversibility of pulmonary hypertension has to be defined by cardiac catheterization, which forms an important part of pre-operative evaluation and selection of candidates for heart transplantation. Fixed pulmonary hypertension is considered a contraindication for orthotopic heart transplantation. In all heart transplant candidates with severe fixed pulmonary hypertension, implantation of left ventricular assist device should be considered to achieve a significant decrease of pulmonary vascular resistance to acceptable values for heart transplantation. Treatment goals in right ventricular failure include preserving coronary perfusion through maintenance of mean arterial pressure, increasing contractility, optimizing right ventricular preload, reducing afterload by decreasing pulmonary vascular resistance, limiting pulmonary vasoconstriction through ventilation with high inspired oxygen concentration and the treatment of arrhythmia. The right ventricular assist device should be implanted when, despite all pulmonary hypertension treatment measures, the right ventricle progressively fails. The implantation should be done timely before the development of multiple organ failure.
Keywords: heart failure; heart transplantation; right ventricle; pulmonary hypertension
Received: March 14, 2013; Accepted: May 28, 2013; Published: December 1, 2013 Show citation
References
- Málek, I. Transplantace srdce - Pohled kardiologa. 1. vyd. Praha: Triton, 2004, 108 s. ISBN 80-7254-510-8.
- Griepp, R., Stinson, E., Dong, E. Jr., Clark, D. A., Shumway, N. E.Determinants of operative risk in human heart transplantation. Am. J. Surg., 1971, 122, p. 192-197.
Go to original source...
Go to PubMed...
- Haddad, F., Couture, P., Tousignant, C., Denault, A. Y. The right ventricle in cardiac surgery, a perioperative perspective:II. Pathophysiology, clinical importance, and management. Anesth. Analg., 2009, 108, p. 422-433.
Go to original source...
Go to PubMed...
- Voelkel, N. F., Quaife, R. A., Leinwand, L. A., Barst, R. J., McGoon, M. D., Meldrum, D. R., Dupuis, J., Long, C. S., Rubin, L. J., Smart, F. W., Suzuki, Y. J., Gladwin, M., Denholm, E. M., Gail, D. B. Right ventricular function and failure: Report of national heart, lung, and blood institute working group on cellular and molecular mechanisms of right heart failure. Circulation, 2006, 114, p. 1883-1891.
Go to original source...
Go to PubMed...
- Kakáč, J., Málek, I., Hrnčárek, M., Želízko, M., Staněk, V. Testování plicní hypertenze u kandidátů ortotopické transplantace srdce pomocí prostaglandinu. E1. Cor. Vasa., 1996, 38, p. 251-255.
- Reichenbach, A., Al-Hiti, H., Málek, I., Pirk, J., Goncalvesová, E., Kautzner, J., Melenovský, V. The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary. Int. J. Cardiol., 2012. Dostupné na www: http://dx.doi.org/10.1016/j.ijcard.2012.09.074.
Go to original source...
Go to PubMed...
- Kettner, J., Dorazilová, Z., Netuka, I., Malý, J., Al-Hiti, H., Melenovský, V., Skalský, I., Říha, H., Málek, I., Kautzner, J., Pirk, J.Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more. Physiol. Res., 2011, 60, p. 769-775.
Go to original source...
Go to PubMed...
- Ho, S. Y., Nihoyannopoulos, P. Anatomy, echocardiography, and normal right ventricular dimensions. Heart, 2006, 92, 1, p. 2-13.
Go to original source...
Go to PubMed...
- Redington, A. N., Gray, H. H., Hodson, M. E., Rigby, M. L., Oldershaw, P. J. Characterisation of the normal right ventricular pressure-volume relation by biplane angiography and simulta-neous micromanometer pressure measurements. Br. Heart. J., 1988, 59, p. 23-30.
Go to original source...
Go to PubMed...
- Rudski, L. G., Lai, W. W., Afilalo, J., Hua, L., Handschumacher, M. D., Chandrasekaran, K., Solomon, S. D., Louie, E. K., Schiller, N. B. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography. J. Am. Soc. Echocardiogr., 2010, 23, p. 685-713.
Go to original source...
Go to PubMed...
- Stobierska-Dzierzek, B., Awad, H., Michler, R. E. Management of Acute Right Heart Failure in Transplant Recipients. JACC, 2001, 38, 4, p. 923-931.
Go to original source...
Go to PubMed...
- Mercat, A., Diehl, J. L., Meyer, G., Teboul, J. L., Sors, H. Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit. Care Med., 1999, 27, p. 540-544.
Go to original source...
Go to PubMed...
- Feissel, M., Michard, F., Mangin, I., Ruyer, O., Faller, J. P., Teboul, J. L. Respiratory Changes in Aortic Blood Velocity as an Indicator of Fluid Responsiveness in Ventilated Patients With Septic Shock. Chest, 2001, 119, p. 867-873.
Go to original source...
Go to PubMed...
- Wagner, F. Monitoring and management of right ventricular function following cardiac transplantation. Applied Cardiopulmonary Pathophysiology, 2011, 15, p. 220-229.
- Moraes, D. L., Colucci, W. S., Givertz, M. M. Secondary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation, 2000, 102, p. 1718-1723.
Go to original source...
Go to PubMed...
- Haraldsson, A., Kieler-Jensen, N., Nathorst-Westfeld, U., Bergh, C. H., Ricksten, S. E. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest, 1998, 114, p. 780-786.
Go to original source...
Go to PubMed...
- Nishimura, M., Hess, D., Kacmarek, R. M., Ritz, B.,Hurford, W. E. Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction. Anesthesiology, 1995, 82, p. 1246-1254.
Go to original source...
Go to PubMed...
- Cuthbertson, B. H., Dellinger, P., Dyar, O. J., Evans, T. E., Higgenbottam, T., Latimer, R., Payen, D., Stott, S. A., Webster, N. R., Young, J. D. UK guidelines for the use of inhaled nitric oxide therapy in adult ICU's. American-European Consensus Conference on ALI/ARDS. Intensive Care Med., 1997, 23, p. 1212-1218.
Go to original source...
Go to PubMed...
- Carrier, M., Blaise, G., Belisle, S., Perfault, L. P., Pellerin, M., Petitclerc, R., Pelletier, L. C. Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation.J. Heart Lung Transplant, 1999, 18, p. 664-667.
Go to original source...
Go to PubMed...
- Maruszewski, M., Zakliczynski, M., Przybylski, R., Kucewicz-Czech, E., Zembala, M. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure. Transplant. Proc., 2007, 39, p. 2850-2852.
Go to original source...
Go to PubMed...
- Channick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainision, M., Bodin, F., Rubin, L. J. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hyperten-sion: a randomised placebo-controlled study. Lancet, 2001, 358, p. 1119-1123.
Go to original source...
Go to PubMed...
- Ošťádal, B., Widimský, J. Intermitent hypoxia and cardiopulmonary system. Academia Praha, 1985, 95, 3, p. 92.
- Fischer, L. G., Van, A. H., Burkle, H. Management of pulmonary hypertension: physiological and pharmacological considera-tions for anesthesiologists. Anesth. Analg., 2003, 96, p.1603-1616.
Go to original source...
Go to PubMed...
- Costanzo, M. R., Dipchand, A., Starling, R., Anderson, A., Chan, M., Desai, S., Fedson, S., Fisher, P., Gonzales-Stawinski, G.,Martinelli, L., McGiffin, D., Parisi, F., Smith, J. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J. Heart Lung Transplant., 2010, 29, 8, p. 914-956.
Go to original source...
Go to PubMed...
- Mentzer, R. M., Alegre, C. A., Nolan, S. P. The effects of dopamine and isoproterenol on the pulmonary circulation. J. Thorac. Cardiovasc. Surg., 1976, 71, p. 807-814.
Go to original source...
Go to PubMed...
- Colluci, W. S. Cardiovascular effects of milrinone. Am. Heart J., 1991, 121, p. 1945-1947.
Go to original source...
Go to PubMed...
- Chen, E. P., Bittner, H. B., Davis, R. D., Van Trigt, P. Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension.J. Heart Lung Transplant., 1998, 17, p. 669-678.
- Kerbaul, F., Rondelet, B., Demester, J. P., Fesler, P., Huez, S., Naeije, R., Brimioulle, S. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit. Care Med., 2006, 34, p. 2814-2819.
Go to original source...
Go to PubMed...
- Missant, C., Rex, S., Segers, P., Wouters, P. F. Levosimendan improves right ventriculovascular coupling in a porcine model of right ventricular dysfunction. Crit. Care Med., 2007, 35, p. 707-715.
Go to original source...
Go to PubMed...
- Netuka, I., Malý, J., Szarszoi, O., Říha, H., Turek, D., Urban, M.,Skalský, I., Kotulák, T., Dorazilová, Z., Pirk, J. Technika implantace a zkušenosti s dočasnou mechanickou srdeční podporou při selhání pravé komory. Rozhl. Chir., 2011, 90, 2, p. 88-94.
Go to PubMed...